Polymorphisms in Candidate Genes for Blood Pressure Regulation in Young Men with Normal or Elevated Screening Blood Pressure

References

• Rostrup M, Kjeldsen SE, Eide IK. Awareness of hyperten-sion increases blood pressure and sympathetic responses to cold pressor test. Am J Hypertens 1990; 3: 912–7.
   Google Scholar
• Rostrup M, Mundal HH, Westheim A, Eide I. Awareness of high blood pressure increases arterial plasma catechol-amines, platelet noradrenaline and adrenergic responses to mental stress. J Hypertens 1991; 9: 159–66.
   PubMed Web of Science ®Google Scholar
• Rostrup M, Westheim A, Kjeldsen SE, Eide I. Cardiovas-cular reactivity, coronary risk factors, and sympathetic activity in young men. Hypertension 1993; 22: 891–9.
   PubMed Web of Science ®Google Scholar
• Moan A, Nordby G, Os I, Birkeland KI, Kjeldsen SE. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism 1994; 43:423–7.
   Google Scholar
• Moan A, Nordby G, Rostrup M, Eide I, Kjeldsen SE. Insulin sensitivity, sympathetic activity, and cardiovascular reac-tivity in young men. Am J Hypertens 1995; 8: 268–75.
   Google Scholar
• Fossum E, HOieggen A, Moan A, Rostrup M, Nordby G, Kjeldsen SE. Relationship between insulin sensitivity and maximal forearm blood flow in young men. Hypertension 1998; 32: 838–43.
   PubMed Web of Science ®Google Scholar
• Fossum E, HOieggen A, Moan A, Rostrup M, Kjeldsen SE. Insulin sensitivity is related to physical fitness and exercise blood pressure to structural vascular properties in young men. Hypertension 1999; 33: 781–6.
   Google Scholar
• HOieggen A, Fossum E, Moan A, Eide I, Kjeldsen SE. Dual effects of adrenalin on blood glucose during hyperinsuline-mia in borderline hypertensive young men. J Hypertens 1999; 17 Suppl 3: S53. Abstract.
   Google Scholar
• Berg K. Role of genetic factors in atherosclerotic disease. Am J Clin Nutr 1989: 49 Suppl 5: 1025–9.
   PubMedGoogle Scholar
• Fossum E, HOieggen A, Moan A, Nordby G, Kjeldsen SE. Insulin sensitivity relates to other cardiovascular risk factors in young men: Validation of some modifications of the hyperinsulinemic, isoglycemic glucose clamp technique. Blood Press 1997; 6: 113–9.
   Google Scholar
• Peuler JD, Johnson GA. Simultaneous single isotope radio-enzymatic assay of plasma norepinephrine, epinephrine and dopamin. Life Sci 1977; 21: 625–36.
   PubMed Web of Science ®Google Scholar
• Kjeldsen SE, Flaaten B, Eide I, Helgeland A, Leren P. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hyperten-sion. Scand J Clin Lab Invest 1982; 42: 217–23.
   Google Scholar
• Bono M, Cases A, Oriola J, Calls J, Torras A, Rivera F. Polymorphisms of the human oc2A-adrenergic receptor gene in a Catalan population: Description of a new polymorphism in the promotor region. Gene Geog 1996: 10: 151–60.
   PubMedGoogle Scholar
• Lario S, Calls J, Cases A, Oriola J, Torras A, Rivera F. MspI identifies a biallelic polymorphism in the promoter region of the oc2A-adrenergic receptor gene. Clin Genet 1997: 51: 129–30.
   PubMedGoogle Scholar
• Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and astmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334–9.
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990: 86: 1343–6.
   Google Scholar
• Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Meth Appl 1993: 3: 120–1.
   PubMedGoogle Scholar
• Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71: 169–80.
   PubMed Web of Science ®Google Scholar
• Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of Met235 -> Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Comm 1993: 197: 833–9.
   Google Scholar
• Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 1994; 24: 63–9.
   PubMed Web of Science ®Google Scholar
• Berge KB, Berg K. Polymorphisms at the angiotensinogen (ATG) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressure. Clin Genet 1998; 53: 214–9.
   PubMedGoogle Scholar
• Siffert W, Rosskopf D, Siffert G, et al. Association of a human G-protein #3 subunit variant with hypertension. Nat Gen 1998; 18: 45–8.
   PubMed Web of Science ®Google Scholar
• Berge KB, BOhn M, Bakken A, Erikssen J, Berg K. Analyses of mutations in the human renal kallikrein (hKLK1) gene and their possible relevance to blood pressure regulation and risk of myocardial infarction. Clin Genet 1997: 52: 86–95.
   Google Scholar
• Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1995, p. 229–72.
   Google Scholar
• Sharma AM, Jeunemaitre X. The future of genetic asso-ciation studies in hypertension; improving the signal-to-noise ratio. J Hypertens 2000; 18: 811–4.
   PubMedGoogle Scholar
• Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged men. Hyperten-sion 1996; 27: 1059–64.
   PubMed Web of Science ®Google Scholar
• Robertson RP, Halter JB, Porte D. A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest 1976; 57: 791–5.
   Google Scholar
• Timmermann B, Mo R, Luft FC, et al. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: the Bergen Blood Pressure Study. Kidney Int 1998; 53: 1455–60.
   PubMedGoogle Scholar
• Katsuya T, Koike G, Yee TVV, et al. Association of angio-tensinogen gene T235 variant with increased risk of coronary heart desease. Lancet 1995; 345: 1600–3.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Wang JiG, Ginocchio G, et al. The deletion/ insertion polmorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15: 1579–92.
   PubMed Web of Science ®Google Scholar
• Berge KE, Berg K. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 1994; 45: 169–74.
   PubMed Web of Science ®Google Scholar
• Panahloo A, Andres C, Mohamed-Ali V, et al. The insertion allele of the ACE gene VD polymorphism. A candidate gene for insulin resistance? Circulation 1995; 92: 3390–3.
   Google Scholar
• Tiret L, Kee F, Poirier 0, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with par-ental history of myocardial infarction. Lancet 1993; 341: 991–2.
   Google Scholar
• BOhn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (VD) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993; 44: 298–301.
   Google Scholar
• Badenhop RF, Wang XL, Wilcken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995; 91: 1655–8.
   Google Scholar
• Berge KE, Berg K. Cardiovascular risk factors in people with different genotypes in the insertion/deletion (I/D) poly-morphism at the locus for angiotensin I-conveting enzyme (ACE). Clin Genet 1997; 52: 422–6.
   PubMedGoogle Scholar
• Berge KE, Bakken A, BOhn M, Eriksen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet 1997; 52: 71–6.
   Google Scholar
• Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and manage-ment. New York: Raven Press, 1990, p. 81–100.
   Google Scholar
• Berg K. Gene—gene interaction:variability gene concept. In: Goldbourt U, de Faire U, Berg K editors. Genetic factors in coronary heart disease. Dordrecht: Kluwer Academic, 1994, p. 373–83.
   Google Scholar
• Pedersen JC, Berg K. Interaction between low density lipoprotein receptor and apolipoprotein E alleles contributes to normal variation in lipid level. Clin Genet 1989; 35: 331–7.
   PubMed Web of Science ®Google Scholar
• Tiret L, Bonnardeaux A, Poirier 0, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphism on risk of myocardial infarc-tion. Lancet 1994; 344: 910–3.
   Google Scholar